COMPLEGENT Trademark

Trademark Overview


On Friday, May 11, 2007, a trademark application was filed for COMPLEGENT with the United States Patent and Trademark Office. The USPTO has given the COMPLEGENT trademark a serial number of 77179157. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Tuesday, May 25, 2021. This trademark is owned by KYOWA HAKKO KOGYO CO., LTD.. The COMPLEGENT trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

[ Host cells for medical or clinical use; cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined oral contracep...

Contract manufacturing service in the field of antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; [ contract manufacturing service in the field of host cells; contract extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals; ] providing information in the field of manufacturing technology in the field of antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of cells that manufacture antibodi...

Development of new products for others in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells; providing technical information in the field of development of new products in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells; technical consultation in the field of development of new products in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibod...
complegent

General Information


Serial Number77179157
Word MarkCOMPLEGENT
Filing DateFriday, May 11, 2007
Status710 - CANCELLED - SECTION 8
Status DateTuesday, May 25, 2021
Registration Number3668133
Registration DateTuesday, August 18, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 2, 2009

Trademark Statements


Goods and Services[ Host cells for medical or clinical use; cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined oral contraceptives, urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidian in chickens, and dysentery in pigs, germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and or agricultural use, antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment for cancer, multienzyme digestants for in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, anti parkinsonism drugs, minor tranquilizers, and anti anxiety agents, medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system, anti-bacterial preparations, monolithic preparations, medicinal preparations for the treatment of peptic ulcers, anti-inflammatory preparations, analgesic preparations, cephalosporin, cocarboxylase preparations, glutathione preparations, preparations for improving the metabolism and the peripheral circulation, plasma substitutes and extracorporeal circulation flow improvement preparations, diuretic and anti-hypertensive preparations, in vitro diagnostic reagents for medical use, in vitro extra corporeal diagnostic reagents for medical use, in vitro x-ray contrast agents for medical use, in vitro diagnostic media, pharmaceutical preparations for the treatment of insomnia and other sleep related diseases ]
Goods and ServicesContract manufacturing service in the field of antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; [ contract manufacturing service in the field of host cells; contract extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals; ] providing information in the field of manufacturing technology in the field of antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies[ ; providing information in the field of manufacturing technology in the field of host cells; technical consultation in the field of manufacturing technology in the field of host cells; providing technical information in the field of extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals technical consultation in the field of extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals ]
Goods and ServicesDevelopment of new products for others in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells; providing technical information in the field of development of new products in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells; technical consultation in the field of development of new products in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies[, and host cells ]

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateTuesday, September 22, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateTuesday, May 25, 2021
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateTuesday, May 25, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKYOWA KIRIN CO., LTD.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressTOKYO 100-0004
JP

Party NameKYOWA HAKKO KIRIN CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCHIYODA-KU, TOKYO 100 8185
JP

Party NameKYOWA HAKKO KIRIN CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCHIYODA-KU, TOKYO
JP

Party NameKYOWA HAKKO KIRIN CO., LTD.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCHIYODA-KU, TOKYO
JP

Party NameKYOWA HAKKO KOGYO CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo
JP

Trademark Events


Event DateEvent Description
Wednesday, May 26, 2021NOTICE OF CANCELLATION SEC. 8 EMAILED
Tuesday, May 25, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, May 25, 2021CANCELLED SEC. 8 (10-YR)
Friday, April 30, 2021PETITION TO DIRECTOR DENIED
Monday, November 2, 2020ASSIGNED TO PETITION STAFF
Thursday, June 25, 2020TEAS PETITION TO DIRECTOR RECEIVED
Wednesday, April 1, 2020POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Thursday, March 12, 2020TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Monday, November 4, 2019POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Wednesday, September 11, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 11, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 11, 2019TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, September 4, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, May 30, 2019POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Thursday, May 30, 2019POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Thursday, May 16, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, April 8, 2019TEAS SECTION 8 & 9 RECEIVED
Saturday, August 18, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, September 22, 2015NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Tuesday, September 22, 2015NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Tuesday, September 22, 2015REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Monday, August 17, 2015REGISTERED - SEC. 8 (6-YR) FILED
Tuesday, September 22, 2015REGISTERED - SEC. 8 (6-YR) ACCEPTED
Friday, September 4, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, August 17, 2015TEAS SECTION 8 RECEIVED
Tuesday, August 18, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, June 2, 2009PUBLISHED FOR OPPOSITION
Wednesday, May 13, 2009NOTICE OF PUBLICATION
Wednesday, April 29, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 27, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 25, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 25, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 25, 2009TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, March 2, 2009LETTER OF SUSPENSION MAILED
Sunday, March 1, 2009SUSPENSION LETTER WRITTEN
Monday, February 9, 2009AMENDMENT FROM APPLICANT ENTERED
Monday, February 9, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 6, 2009PAPER RECEIVED
Monday, January 12, 2009INQUIRY AS TO SUSPENSION MAILED
Sunday, January 11, 2009SUSPENSION INQUIRY WRITTEN
Friday, January 9, 2009LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, November 19, 2008AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, July 9, 2008LETTER OF SUSPENSION MAILED
Tuesday, July 8, 2008SUSPENSION LETTER WRITTEN
Wednesday, June 11, 2008AMENDMENT FROM APPLICANT ENTERED
Wednesday, June 11, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 9, 2008PAPER RECEIVED
Wednesday, March 26, 2008INQUIRY AS TO SUSPENSION MAILED
Tuesday, March 25, 2008SUSPENSION INQUIRY WRITTEN
Sunday, February 24, 2008LIE CHECKED SUSP - TO ATTY FOR ACTION
Sunday, February 24, 2008ASSIGNED TO LIE
Friday, August 24, 2007LETTER OF SUSPENSION MAILED
Friday, August 24, 2007SUSPENSION LETTER WRITTEN
Friday, August 24, 2007ASSIGNED TO EXAMINER
Wednesday, May 16, 2007NEW APPLICATION ENTERED IN TRAM